Nyxoah receives $15 million from European Investment Bank

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

Nyxoah has received $15 million from the European Investment Bank as the second tranche of its loan facility. The drawdown follows confirmation that the company met predefined criteria, and brings total new capital raised in June 2026 to approximately $110 million when combined with the proceeds of its recent underwritten public offering. The non-dilutive funding will primarily accelerate the commercial launch of the Genio system in the United States, while also supporting research and development and manufacturing scale-up. CEO Olivier Taelman called the financing transformative and a strong endorsement of the company's technology.

Impact on stocks 1

Health Care · 1 stocks
Nyxoah
NYXH
▲ PositiveCapitalrelevance

Nyxoah receives $15M non-dilutive loan tranche from EIB, adding to ~$110M raised in June 2026 to fund US launch and R&D.